DMAAU NASDAQ
Drugs Made In America Acquisition Corp. Units
1W: +0.0%
1M: +1.9%
3M: +3.6%
YTD: +4.6%
1Y: +5.8%
$10.89
-0.10 (-0.91%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$172K
+0.0% ▲
Capital Expenditures
$5
+0.0% ▲
Free Cash Flow
-$295
+0.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$1K
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2024 |
|---|---|
| — Operating Activities — | |
| Net Income | -$479 |
| Depreciation & Amort. | $0 |
| Stock-Based Comp. | $0 |
| Change in Working Capital | $132 |
| Other Non-Cash Items | -$172K |
| Operating Cash Flow | -$172K |
| — Investing Activities — | |
| Capital Expenditures | $0 |
| Acquisitions (Net) | $0 |
| Investment Purchases | $0 |
| Investment Sales | $0 |
| Other Investing | $0 |
| Investing Cash Flow | $0 |
| — Financing Activities — | |
| Net Debt Issuance | $502K |
| Stock Repurchased | $0 |
| Dividends Paid | $0 |
| Other Financing | $0 |
| Financing Cash Flow | $174K |
| Net Change in Cash | $1K |
| Cash End of Period | $1K |
| Free Cash Flow | -$295 |